News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SQI Diagnostics Granted Multiple U.S, EU and CDN Patents for Novel Multiplexing Technologies


9/21/2012 9:41:00 AM

TORONTO--(BUSINESS WIRE)--SQI Diagnostics Inc. (TSX-V: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has been granted multiple patents for its multiplexing platform and assay technologies. SQI has a total of 13 patents protecting multiple aspects of SQI Diagnostics’ multiplexing technologies.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES